Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking

Laurence Leherte1, Axel Petit2, Denis Jacquemin3,4

  • 1Laboratoire de Physico-Chimie Informatique, Unité de Chimie Physique Théorique et Structurale, Department of Chemistry, NAmur MEdicine and Drug Innovation Center (NAMEDIC), Namur Institute of Structured Matter (NISM), University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium. laurence.leherte@unamur.be.

Summary

Molecular dynamics simulations reveal that the cyclic CD58 ligand P6 exhibits higher affinity due to reduced flexibility and increased hydrogen bonds with CD58, offering insights into T cell recognition. Further analysis supports experimental findings.